mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
-0.13 |
0.4 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.4 |